| Literature DB >> 30093944 |
Zhi-Xiao Su1,2, Yi-Qin Shi3, Zhao-Yang Lu2, Rui-Lin Li2, Xue-Lian Wang2, Bing-Bing Ning2, Jun-Li Duan2, Liang-Shi Hao2, Jun-Hui Duan4, Yue Li5, Ying-Jie Zhu6, Chang-Ning Hao4, Rui Wang1.
Abstract
Nanostructured calcium phosphate (CaP) and magnesium phosphate (MgP) are promising for the application as the nanocarriers in drug delivery. However, the difference between CaP and MgP nanocarriers in drug delivery is rarely investigated. In this work, we comparatively investigated nanostructured CaP, MgP and calcium magnesium phosphate (CMP) for the delivery of SRT1720, which is a silent information regulator (SIRT1) specific activator with pro-angiogenic and anti-aging properties in response to hydrogen peroxide (H2O2)-induced endothelial senescence. The protection of SRT1720-loaded CaP nanospheres, MgP nanosheets and CMP microspheres on the H2O2-induced senescent endothelium was examined by using human umbilical vein endothelial cells (HUVECs), demonstrating the improved cell viability, anti-aging, tube formation and migration. In addition, the SRT1720-loaded CaP nanospheres, MgP nanosheets and CMP microspheres can rescue the impaired angiogenic potential of HUVECs via activation of Akt/eNOS/VEGF pathway. The SRT1720-loaded MgP nanosheets and CMP microspheres have a similar protective effect compared with the pure SRT1720, while the SRT1720-loaded CaP nanospheres decrease the protective capability of SRT1720. These results lead us to figure out both MgP nanosheets and CMP microspheres are suitable and effective delivery for SRT1720 and this system can be further applied in vivo treatment.Entities:
Keywords: Nanostucture; SRT1720; calcium phosphate; endothelial cell senescence; magnesium phosphate
Year: 2018 PMID: 30093944 PMCID: PMC6079123
Source DB: PubMed Journal: Am J Transl Res ISSN: 1943-8141 Impact factor: 4.060